Active Member
|
[China]
Address: 301,Building B1,Compass Life Science Industrial Park, Julongshan Road A, Pingshan District, Shenzhen,China
Contact name:Meiko Wu
Shenzhen Kisshealth Biotechnology Co., Ltd |
|
|
Rapid Antigen Detection Kit Nasal (GICA)
Product specifications
Application | In vitro qualitative detection of nucleocapsid(N) protein antigen from Covid-19 virus in human nasal (anterior) swab. |
Main Composition | Test Cassette, Swab, Sample Extraction Bottle, Sample Extraction Tube, Tube Cap, Dropper, IFU |
Function | Covid-19 Detection |
Specimen | Nasal |
Advantage | High specificity and high sensitivity |
Usage | Self-test |
Principle of the procedure
The SARS-CoV-2 Antigen Test Kit (GICA) uses the lateral flow immuno-chromatographic sandwich assay to detect nucleocapsid protein of SARS-CoV-2 in nasopharyngeal swabs or nasal swabs.
The patient sample is placed in the Sample Tube, during which time the virus particles in the sample are disrupted, exposing internal viral nucleoproteins. After disruption, the sample is dispensed into the Test Cassette sample well. And the sample migrates through a test strip, if the SARS-CoV-2 virus antigen is present, a red color line will be showed on the T site. If SARS-CoV-2 viral antigen is absent, there is not a red line will be showed on the T site, however, a red line will be always showed on the C site indicating that the reaction system is properly happened.
Test procedure
1. Twist off the buffer, dispense all of the buffer into the
extraction tub.
2. Sample collecting.
3. Elution of samples from swabs
4. Sample adding
5. 15 minutes for result
6. Result Interpretation
